Review Article

Gynecological Care and Contraception Considerations in Women with Cerebral Palsy

Authors: Madeline Fasen, DO, Brittany Saldivar, Suhane Elamsenthi, Jordan Thompson, Lina Fouad, MD, Linda Edwards, MD, Rafik Jacob, MD

Abstract

The purpose of this literature review was to further explore gynecological care and contraceptive use in women with cerebral palsy. We address barriers to pelvic examinations for cervical cancer screenings and current contraceptive methods in severely debilitated patients with cerebral palsy.

 
Posted in: Neurology16 Obstetrics and Gynecology55

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Turk MA, Scandale J, Rosenbaum PP, et al. The health of women with cerebral palsy. Phys Med Rehabil Clin N Am 2001;12:153–168. 2. Shelley P, Edwards L, Jacob R. The potential benefits of PTH analogs in prevention of pathological fractures in cerebral palsy. J Child Dev Disord 2019;5:8. 3. Quint EH. Menstrual and reproductive issues in adolescents with physical and developmental disabilities. Obstet Gynecol. 2014;124(2, PART 1):367–375. 4. Steele CB, Townsend JS, Courtney-Long EA, et al. Prevalence of cancer screening among adults with disabilities, United States, 2013. Prev Chronic Dis. 2017;14:160–312. 5. Nosek MA, Howland CA. Breast and cervical cancer screening among women with physical disabilities. Arch Phys Med Rehabil 1997;78(suppl 5):S39–S44. 6. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus isa necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12–19. 7. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003;16:1–17. 8. Wiegerink DJHG, Roebroeck ME, Donkervoort M, et al. Social and sexual relationships of adolescents and young adults with cerebral palsy: a review. Clin Rehabil 2006;20:1023–1031. 9. Murphy NA, Elias ER. Sexuality of children and adolescents with developmental disabilities. Pediatrics 2006;118:398–403. 10. Baladerian NJ. Sexual abuse of people with developmental disabilities. Sex Disabil 1991;9:323–335. 11. Rowe M, Pritt AL, Stratton AJ, et al. HPV vaccination among females with mental and physical limitation. Marshall J Med 2017;3:45. 12. Taouk LH, Fialkow MF, Schulkin JA. Provision of reproductive healthcare to women with disabilities: a survey of obstetrician-gynecologists’ training, practices, and perceived barriers. Health Equity 2018;2:207–215. 13. Haynes RM, Boulet SL, Fox MH, et al. Contraceptive use at last intercourse among reproductive-aged women with disabilities: an analysis of population-based data from seven states. Contraception 2018;97:538–545. 14. Wiegerink DJHG, Roebroeck ME, Donkervoort M, et al. Social, intimate and sexual relationships of adolescents with cerebral palsy compared with able-bodied age-mates. J Rehabil Med 2008;40:112–118. 15. Quint EH, O’Brien RF. Menstrual management for adolescents with disabilities. Pediatrics 2016;138:e20160295. 16. Kirkham YA, Allen L, Kives S, et al. Trends in menstrual concerns and suppression in adolescents with developmental disabilities. J Adolesc Health 2013;53:407–412. 17. Courtney-Long EA, Carroll DD, Zhang QC, et al. Prevalence of disability and disability type among adults, United States—2013. Morb Mortal Wkly Rep 2015;64:777–783. 18. Wu J, Zhang J, Mitra M, et al. Provision of moderately and highly effective reversible contraception to insured women with intellectual and developmental disabilities. Obstet Gynecol 2018;132:565–574. 19. Jirakittidul P, Somyaprasert C, Angsuwathana S. Prevalence of documented excessive weight gain among adolescent girls and young women using depot medroxyprogesterone acetate. J Clin Med Res 2019;11:326–331. 20. Hubacher D, Lopez L, Steiner MJ, et al. Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception 2009;80:113–118.